Msd Drug Patent Portfolio
Msd owns 1 orange book drug protected by 1 US patent Given below is the list of Msd's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| USRE46791 | Substituted dihydroquinazolines | 18 Jan, 2029 | Active |
Latest Legal Activities on Msd's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Msd.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
|
Email Notification
Critical
| 01 May, 2024 | US10603384 |
|
Email Notification
Critical
| 30 Apr, 2024 | US10603384 |
| Recordation of Patent eCertificate of Correction | 30 Apr, 2024 | US10603384 |
| Mail Patent eCofC Notification | 30 Apr, 2024 | US10603384 |
| Patent eCofC Notification | 30 Apr, 2024 | US10603384 |
| Post Issue Communication - Certificate of Correction | 10 Apr, 2024 | US10603384 |
|
Withdrawal of Application for PTE
Critical
| 07 Feb, 2024 | US8513255 |
| Election in Response to Notice of Final Determination | 27 Dec, 2023 | US8513255 |
| Notice of Final Determination -Election Required | 14 Dec, 2023 | US8513255 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 12 Sep, 2023 | US10603384 |
|
FDA Final Eligibility Letter
Critical
| 13 Jul, 2023 | US8513255 |
| transaction for FDA Determination of Regulatory Review Period | 08 Sep, 2022 | US8513255 |
| Second letter to regulating agency to determine regulatory review period | 31 Mar, 2021 | US8513255 |
|
Email Notification
Critical
| 24 Mar, 2021 | US10603384 |
| Mail-Record a Petition Decision of Granted to Issue Patent in Name of the Assignee | 23 Mar, 2021 | US10603384 |
Msd's Family Patents
Msd Drug List
Given below is the complete list of Msd's drugs and the patents protecting them.
1. Prevymis
Prevymis is protected by 1 patent, which is still active. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| USRE46791 | Substituted dihydroquinazolines |
18 Jan, 2029
(4 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Prevymis's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List